Dopaminergic system modulation of nociceptive response in long-term diabetic rats

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 1, 2002, Pages 1-9

  Rutledge, L P ^a   Ngong, J M ^a   Kuperberg, J M ^a   Samaan, S S ^a   Soliman, K F A ^a   Kolta, M G ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Bromocriptine; Diabetes; Haloperidol; Met enkephalin; Nociceptive response; Rat

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; ILENTIN; INSULIN; METENKEPHALIN; STREPTOZOCIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; DISSECTION; DOPAMINERGIC SYSTEM; DRUG EFFECT; HOT PLATE TEST; HYPOPHYSIS; INSULIN TREATMENT; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; RECEPTOR SENSITIVITY; SPINAL CORD; STREPTOZOCIN DIABETES; TISSUE LEVEL; TREATMENT OUTCOME;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BRAIN CHEMISTRY; BROMOCRIPTINE; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ENKEPHALIN, METHIONINE; HALOPERIDOL; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NOCICEPTORS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; SPINAL CORD; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0036887543     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00949-8     Document Type: Article

References (33)

1. Akunne H.C., Soliman K.F.A. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology. 93:1987;167-172.
2. Blanc D., Cupo A., Castanas E., Bourghim N., Giraud P., Bannon M.J., Eiden L.E. Influence of acute, subchronic and chronic treatment with neuroleptic (haloperidol) on enkephalins and their precursors in the striatum of rat brain. Neuropeptides. 5:1985;567-570.
3. Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiologic functions and in brain monoamines content in streptozotocin-diabetic rats. Diabetes. 35:1986;481-485.
4. Coudore-Civiale M.A., Meen M., Fournie-Zaluski M.C., Boucher M., Roques B.P., Eschalier A. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats. Br. J. Pharmacol. 133:2001;179-185.
5. Forman L.J., Estilow S., Lewis M., Vasilenko P. Streptozocin diabetes alters immunoreactive β-endorphin levels and pain perception after 8 wk in female rats. Diabetes. 35:1986;1309-1313.
6. Frussa-Filho R., Rocha J.B., Conceicao I.M., Mello C.F., Pereira M.E. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Arch. Int. Pharmacodyn. Ther. 331:1996;74-93.
7. George S.R., Kertesz M. Met-enkephalin-like immunoreactivity in neurointermediate pituitary is decreased by DA receptor stimulation. Peptides. 7:1986;277-281.
8. George S.R., Kertesz M. Met-enkephalin concentrations in the striatum respond reciprocally to alterations in dopamine neurotransmission. Peptides. 8:1987;487-492.
9. Hong J.S., Yang H.Y., Gillin J.C., Di Giulio A.M., Fratta W., Costa E. Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res. 160:1979;192-195.
10. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-580.
11. Kamei J., Saitoh A. Involvement of dopamine D2-receptor-mediated functions in the modulation of morphine-induced antinociception in diabetic mouse. Neuropharmacology. 35:1996;273-278.
12. Kamei J., Kashiwazaki T., Hitosugi H., Nagase H. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice. Eur. J. Pharmacol. 326:1997;31-36.
13. Kamei J., Zushida K., Ohsawa M., Nagase H. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. Eur. J. Pharmacol. 391:2000;91-96.
14. Kiritsy-Roy J.A., Standish S.M., Terry L.C. Dopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacol. Biochem. Behav. 32:1989;717-721.
15. Kolta M.G., Pierzchala K., Houdi A.A., Van Loon G.R. Effect of diabetes on the levels of two forms of Met-enkephalin in plasma and peripheral tissues of the rat. Neuropeptides. 21:1992;55-63.
16. Kolta M.G., Ngong J.M., Rutledge L.P., Pierzchala K., Van Loon G.R. Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides. 30:1996;335-344.
17. Kosterlitz H.W., Hughes J. Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci. 17:1975;91-96.
18. Lin Y., Morrow T.J., Kiritsy-Roy J.A., Terry L.C., Casey K.L. Cocaine: evidence for supraspinal, dopamine-mediated, non-opiate analgesia. Brain Res. 479:1989;306-312.
19. Llorens-Cortes C., Zini S., Gros C., Schwartz J.C. Dopaminergic regulation of enkephalin release. J. Neurochem. 56:1991;1368-1375.
20. Mocchetti I., Schwartz J.P., Costa E. Use of mRNA hybridization and radioimmunoassay to study mechanisms of drug-induced accumulation of enkephalin in rat brain structures. Mol. Pharmacol. 28:1985;86-91.
21. Morgan M.J., Franklin K.B. Dopamine receptor subtypes and formalin test analgesia. Pharmacol. Biochem. Behav. 40:1991;317-322.
22. Morley G.K., Mooradian A.D., Levine A.S., Morley J.E. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am. J. Med. 77:1984;79-82.
23. Morris B.J., Hollt V., Herz A. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists. Neuroscience. 25:1988;525-532.
24. Sabol S.L., Yoshikawa K., Hong J.S. Regulation of methionine-enkephalin precursor messenger RNA in rat striatum by haloperidol and lithium. Biochem. Biophys. Res. Commun. 113:1983;391-399.
25. Sahley T.L., Berntson G.G. Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology. 65:1979;279-283.
26. Shook J.E., Dewey W.L. Morphine dependence and diabetes. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice. J. Pharmacol. Exp. Ther. 237:1986;841-847.
27. Simon G.S., Dewey W.L. Narcotics and diabetes: I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J. Pharmacol. Exp. Ther. 218:1981;318-323.
28. Simon G.S., Borzelleca J., Dewey W.L. Narcotics and diabetes: II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics: mechanism of diabetes: morphine interaction. J. Pharmacol. Exp. Ther. 218:1981;324-329.
29. Sivam S.P., Strunk C., Smith D.R., Hong J.S. Preproenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol. Mol. Pharmacol. 30:1986;186-191.
30. Suandeau C., Costentin J. Analgesic effect of the direct D2 dopamine receptor agonist RU 24926 and cross tolerance with morphine. Fundam. Clin. Pharmacol. 9:1995;147-152.
31. Takeshita N., Yamaguchi I. Antinociceptive effects of morphine were different between experimental and genetic diabetes. Pharmacol. Biochem. Behav. 60:1998;889-897.
32. Tang F. Effect of reserpine on catecholamine contents and met-enkephalin and beta-endorphin levels in the hypothalamus and the pituitary. Clin. Exp. Pharmacol. Physiol. 18:1991;425-429.
33. Tang F., Costa E., Schwartz J.P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. Natl Acad. Sci. U.S.A. 80:1983;3841-3844.